Skip to main content
. 2022 Feb 3;8:812631. doi: 10.3389/fcvm.2021.812631

Figure 1.

Figure 1

Therapeutic drugs for RA are a double-edged sword in case of RA-induced CVDs. Some drugs may reduce the incidence of CVDs in patients with RA by inhibiting inflammation and improving endothelial function and insulin resistance, and some drugs may impair the mechanism of vascular repair, have harmful effects on the cardiovascular system, and increase the risk of developing CVDs. We will explain the effects of these drugs on the cardiovascular risk of patients with RA.